Dr. Lissette D. Cortazar, MD

Dr. Cortazar practices at Lissette D Cortazar MDPA in Miami, Florida.

Dr. Cortazar's NPI, 1477850410, was assigned on February 25, 2011. Dr. Cortazar graduated from Instituto Superior de Ciencias Médicas de la Habana in 1995. Dr. Cortazar holds Florida license ME129982.

Dr. Cortazar's primary practice is Lissette D Cortazar MDPA, at 3661 S Miami Ave, Miami, FL 33133 in Miami-Dade County. The practice phone is (305) 815-0055.

Dr. Cortazar's primary practice is Lissette D Cortazar MDPA in Miami, Florida. Dr. Cortazar is also affiliated with Coral West Community Hospital. The medical group on file is Dr. Lissette D. Cortazar, MD. Dmand AI also links Dr. Cortazar to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cortazar practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Cortazar's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Cortazar is licensed in Florida.

Dmand AI lists anxiety, bipolar disorder, depression, insomnia, intellectual and developmental disabilities and schizophrenia among the conditions Dr. Cortazar treats.

CMS data shows 10,578 Medicare services from Dr. Cortazar across 16 procedure codes in 2024, for 1,525 Medicare patients. Medicare paid $800,928 for them.

CMS counts 1,525 Medicare patients who saw Dr. Cortazar in 2024. The largest group is 85 and over, with 546 patients. 75% of them have anxiety, and 75% have depression. 88% are also on Medicaid. Their average risk score is 3.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cortazar's median patient age at 78, with 60% women.

In 2024, Dr. Cortazar wrote 8,670 Medicare Part D claims for 501 patients. 99% of them were for generic drugs. CMS names the drug for 8,543 of them, across 40 drugs with 11 or more claims each, at $79,994 in total drug cost. In 2023, CMS named 7,097 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Cortazar for performance year 2024, reported individually. Dr. Cortazar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cortazar as offering telehealth.

Dmand AI links Dr. Cortazar to 1 clinical trial. Conditions studied include Alzheimer Disease and Tauopathies.

CMS Open Payments shows 94 general payments to Dr. Cortazar from 16 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Allergan Inc. paid the most, $434.

Dr. Cortazar graduated from Instituto Superior de Ciencias Médicas de la Habana in 1995.

Dr. Cortazar is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.